Home Compare LLY vs UCB.BR
Stock Comparison · Comparison

Eli Lilly and Company vs UCB: Which Stock Looks Stronger in 2026?

Eli Lilly and Company holds the cleaner structural position, with profitability as the main driver and stability adding further support. UCB still has the edge on stability, which keeps the comparison from looking entirely one-sided. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both profitability and growth materially support the lead. Eli Lilly and Company leads by 9 points on the overall comparison score.

Trajectory Similarity
0.62
Moderately similar
Peer-set rank: #8
within Eli Lilly and Company's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The match is driven mainly by margin trend and capital structure.

Similarity drivers
margin trendcapital structure
What reduces the match
revenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
LLY
Eli Lilly and Company
68
Peer-Score
Signal qualityHigh
vs
UCB.BR
UCB SA
59
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: LLY vs UCB.BR Profitability 100 64 Stability 34 67 Valuation 44 42 Growth 88 66 LLY UCB.BR
Gap Ranking
#1 Profitability +36
#2 Stability +33
#3 Growth +22
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for LLY and UCB.BR Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer LLYUCB.BR Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both rank well on profitability, but Eli Lilly and Company still holds a clear edge.
Stability
The same broad pattern appears on stability: UCB SA ranks near the top of the group, while Eli Lilly and Company stays in the weaker half.
Profitability — Dominant Gap
LLY
100
UCB.BR
64
Gap+36in favour of LLY

The profitability lead is mainly driven by a 14.5-point operating margin advantage.

What keeps the gap from being one-sided

Stability still tilts materially toward UCB SA, which stops the result from looking dominant across the whole profile.

What this means for the comparison

The profitability edge is decisive, even though current pricing and stability still lean somewhat toward UCB SA.

Explore full peer positioning in AssetNext

Break down the LLY vs UCB.BR comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how LLY and UCB.BR each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.